<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>PS3/BS3 Analysis Report</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            line-height: 1.6;
            color: #333;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 20px;
        }
        .container {
            max-width: 1200px;
            margin: 0 auto;
            background: white;
            border-radius: 8px;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
            overflow: hidden;
        }
        .header {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 30px;
            text-align: center;
        }
        .header h1 {
            font-size: 2.5em;
            margin-bottom: 10px;
        }
        .header p {
            font-size: 1.1em;
            opacity: 0.9;
        }
        .content {
            padding: 30px;
        }
        .section {
            margin-bottom: 30px;
            border-left: 4px solid #667eea;
            padding-left: 20px;
        }
        .section h2 {
            font-size: 1.8em;
            color: #667eea;
            margin-bottom: 15px;
        }
        .info-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 20px;
            margin-bottom: 20px;
        }
        .info-card {
            background: #f8f9fa;
            padding: 15px;
            border-radius: 5px;
            border: 1px solid #e9ecef;
        }
        .info-card .label {
            font-weight: bold;
            color: #667eea;
            font-size: 0.9em;
            text-transform: uppercase;
        }
        .info-card .value {
            font-size: 1.1em;
            margin-top: 5px;
            word-break: break-word;
        }
        .assessment-box {
            background: #f0f4ff;
            border: 2px solid #667eea;
            border-radius: 8px;
            padding: 20px;
            margin: 20px 0;
        }
        .assessment-decision {
            font-size: 1.5em;
            font-weight: bold;
            margin-bottom: 10px;
        }
        .ps3 {
            color: #d32f2f;
        }
        .bs3 {
            color: #388e3c;
        }
        .none {
            color: #f57c00;
        }
        .narrative {
            font-size: 1.05em;
            line-height: 1.8;
            margin-top: 10px;
        }
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
        }
        th {
            background: #f0f4ff;
            color: #667eea;
            padding: 12px;
            text-align: left;
            font-weight: 600;
            border-bottom: 2px solid #667eea;
        }
        td {
            padding: 12px;
            border-bottom: 1px solid #e9ecef;
        }
        tr:hover {
            background: #f8f9fa;
        }
        .badge {
            display: inline-block;
            padding: 5px 12px;
            border-radius: 20px;
            font-size: 0.85em;
            font-weight: 600;
            margin-right: 5px;
        }
        .badge-paper {
            background: #e3f2fd;
            color: #1565c0;
        }
        .badge-experiment {
            background: #f3e5f5;
            color: #6a1b9a;
        }
        .badge-supporting {
            background: #c8e6c9;
            color: #2e7d32;
        }
        .badge-ambiguous {
            background: #ffe0b2;
            color: #e65100;
        }
        .experiment-item {
            background: #fafafa;
            padding: 15px;
            margin: 15px 0;
            border-radius: 5px;
            border-left: 4px solid #764ba2;
        }
        .experiment-item .key {
            font-weight: 600;
            color: #764ba2;
        }
        .footer {
            background: #f8f9fa;
            padding: 20px;
            text-align: center;
            border-top: 1px solid #e9ecef;
            color: #666;
            font-size: 0.9em;
        }
        .stats {
            display: flex;
            gap: 20px;
            margin: 20px 0;
            flex-wrap: wrap;
        }
        .stat-box {
            flex: 1;
            min-width: 150px;
            background: #f8f9fa;
            padding: 20px;
            border-radius: 5px;
            text-align: center;
        }
        .stat-number {
            font-size: 2em;
            font-weight: bold;
            color: #667eea;
        }
        .stat-label {
            color: #666;
            font-size: 0.9em;
            margin-top: 5px;
        }
    </style>
</head>
<body>
    <div class="container">
        <div class="header">
            <h1>PS3/BS3 Functional Evidence Analysis</h1>
            <p>ACMG Variant Classification Report</p>
        </div>

        <div class="content">
            <!-- Variant Information Section -->
            <div class="section">
                <h2>1. Variant Information</h2>
                <div class="info-grid">
                    <div class="info-card">
                        <div class="label">Genomic Coordinates</div>
                        <div class="value">2:162279995</div>
                    </div>
                    <div class="info-card">
                        <div class="label">Alleles</div>
                        <div class="value">C → G</div>
                    </div>
                    <div class="info-card"><div class="label">Gene Symbol</div><div class="value">IFIH1</div></div>
                    <div class="info-card"><div class="label">rsID</div><div class="value">rs35337543</div></div>
                    <div class="info-card"><div class="label">HGVSc</div><div class="value">ENST00000649979.2:c.1641+1G>C</div></div>
                    
                </div>
            </div>

            <!-- Literature Summary Section -->
            <div class="section">
                <h2>2. Literature Summary</h2>
                <div class="stats">
                    <div class="stat-box">
                        <div class="stat-number">55</div>
                        <div class="stat-label">Candidate Papers</div>
                    </div>
                    <div class="stat-box">
                        <div class="stat-number">3</div>
                        <div class="stat-label">Functional Papers</div>
                    </div>
                    <div class="stat-box">
                        <div class="stat-number">3</div>
                        <div class="stat-label">Experiments</div>
                    </div>
                </div>
                
    <table>
        <thead>
            <tr>
                <th>PMID</th>
                <th>Title</th>
                <th>Justification</th>
            </tr>
        </thead>
        <tbody>
            
        <tr>
            <td><span class="badge badge-paper">20844740</span></td>
            <td>Reduced expression of IFIH1 is protective for type 1 diabetes....</td>
            <td>The paper provides experimental functional data showing redu...</td>
        </tr>
        
        <tr>
            <td><span class="badge badge-paper">28606988</span></td>
            <td>Recurrent rhinovirus infections in a child with inherited MDA5 deficiency....</td>
            <td>The paper provides experimental functional data showing that...</td>
        </tr>
        
        <tr>
            <td><span class="badge badge-paper">34726731</span></td>
            <td>Inborn errors of TLR3- or MDA5-dependent type I IFN immunity in children with en...</td>
            <td>The paper provides experimental functional data on the homoz...</td>
        </tr>
        
        </tbody>
    </table>
    
            </div>

            <!-- Experiments Section -->
            <div class="section">
                <h2>3. Functional Experiments</h2>
                
        <div class="experiment-item">
            <div><span class="key">Experiment 1 (PMID 28606988)</span> <span class="badge badge-supporting">supports_pathogenic</span></div>
            <p><span class="key">Assay Type:</span> luciferase reporter</p>
            <p><span class="key">System:</span> HEK293 cells</p>
            <p><span class="key">Readout:</span> luciferase activity from the IFNB1 promoter</p>
            <p><span class="key">Effect Direction:</span> strong_loss_of_function</p>
            <p><span class="key">Magnitude & Stats:</span> Mutant MDA5 failed to drive luciferase activity; specific p-values not provided.</p>
            <p><span class="key">Controls & Quality:</span> Wild-type MDA5 was used as a control; the experiment was conducted in a standard cell line with appropriate controls.</p>
            <p><span class="key">Authors' Conclusion:</span> The mutant MDA5 does not function properly in recognizing dsRNA and fails to activate the IFNB1 promoter, indicating a damaging effect of the variant.</p>
        </div>
        
        <div class="experiment-item">
            <div><span class="key">Experiment 2 (PMID 28606988)</span> <span class="badge badge-supporting">supports_pathogenic</span></div>
            <p><span class="key">Assay Type:</span> viral replication assay</p>
            <p><span class="key">System:</span> patient fibroblasts</p>
            <p><span class="key">Readout:</span> replication of human rhinovirus (HRV)</p>
            <p><span class="key">Effect Direction:</span> strong_loss_of_function</p>
            <p><span class="key">Magnitude & Stats:</span> Increased replication of HRV was observed in fibroblasts expressing mutant MDA5; specific fold-changes not provided.</p>
            <p><span class="key">Controls & Quality:</span> Fibroblasts from the patient were compared to wild-type controls; the results were consistent across multiple experiments.</p>
            <p><span class="key">Authors' Conclusion:</span> The mutant MDA5 leads to increased susceptibility to HRV infection, indicating a loss of function in the immune response.</p>
        </div>
        
        <div class="experiment-item">
            <div><span class="key">Experiment 3 (PMID 34726731)</span> <span class="badge badge-supporting">supports_pathogenic</span></div>
            <p><span class="key">Assay Type:</span> fibroblast response to stimulation</p>
            <p><span class="key">System:</span> patient fibroblasts</p>
            <p><span class="key">Readout:</span> IFN-β levels</p>
            <p><span class="key">Effect Direction:</span> strong_loss_of_function</p>
            <p><span class="key">Magnitude & Stats:</span> Baseline and EV-responsive levels of IFN-β are low in patient fibroblasts; specific p-values not provided.</p>
            <p><span class="key">Controls & Quality:</span> Fibroblasts from patients with the variant were compared to controls; the study indicates a clear functional impairment in the variant carriers.</p>
            <p><span class="key">Authors' Conclusion:</span> The homozygous IFIH1 variant (c.1641+1G>C) leads to a loss of function in the IFIH1 gene, resulting in impaired type I IFN production in response to viral infection.</p>
        </div>
        
            </div>

            <!-- Assessment Section -->
            <div class="section">
                <h2>4. ACMG Assessment</h2>
                <div class="assessment-box">
                    <div class="assessment-decision">
                        Decision: 
                        <span class="ps3">
                            PS3
                        </span>
                    </div>
                    <div class="stat-label">Strength: STRONG</div>
                    <div class="narrative">
                        3 experiment(s) across 2 paper(s) reported impaired or abnormal function consistent with a damaging effect. Taken together, these studies provide functional evidence supporting a damaging effect on the gene product, compatible with application of PS3 (strong strength).
                    </div>
                    <p style="margin-top: 15px; font-size: 0.9em;"><strong>Key PMIDs:</strong> 28606988, 34726731</p>
                </div>
            </div>
        </div>

        <div class="footer">
            <p>Report generated by PS3/BS3 Analysis Pipeline</p>
            <p>For more information, visit: <a href="https://github.com/AliSaadatV/AcmGENTIC" style="color: #667eea;">AcmGENTIC on GitHub</a></p>
        </div>
    </div>
</body>
</html>